165 related articles for article (PubMed ID: 10504060)
1. Mapping of occult melanoma micrometastases in the inguinal lymph node basin by immunohistochemistry and RT-PCR.
Hatta N; Fujimoto A; Takehara K; Takata M
Melanoma Res; 1999 Aug; 9(4):401-6. PubMed ID: 10504060
[TBL] [Abstract][Full Text] [Related]
2. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin.
Blaheta HJ; Schittek B; Breuninger H; Sotlar K; Ellwanger U; Thelen MH; Maczey E; Rassner G; Bueltmann B; Garbe C
Am J Surg Pathol; 1999 Jul; 23(7):822-8. PubMed ID: 10403306
[TBL] [Abstract][Full Text] [Related]
3. Polymerase chain reaction and immunohistochemistry frequently detect occult melanoma cells in regional lymph nodes of melanoma patients.
Hatta N; Takata M; Takehara K; Ohara K
J Clin Pathol; 1998 Aug; 51(8):597-601. PubMed ID: 9828818
[TBL] [Abstract][Full Text] [Related]
4. Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma?
Blaheta HJ; Sotlar K; Breuninger H; Bueltmann B; Rassner G; Garbe C; Horny HP
Melanoma Res; 2001 Feb; 11(1):57-63. PubMed ID: 11254116
[TBL] [Abstract][Full Text] [Related]
5. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.
Bieligk SC; Ghossein R; Bhattacharya S; Coit DG
Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881
[TBL] [Abstract][Full Text] [Related]
6. Lymph node micrometastases of cutaneous melanoma: increased sensitivity of molecular diagnosis in comparison to immunohistochemistry.
Blaheta HJ; Schittek B; Breuninger H; Maczey E; Kroeber S; Sotlar K; Ellwanger U; Thelen MH; Rassner G; Bültmann B; Garbe C
Int J Cancer; 1998 Aug; 79(4):318-23. PubMed ID: 9699521
[TBL] [Abstract][Full Text] [Related]
7. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma.
Blaheta HJ; Schittek B; Breuninger H; Garbe C
Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study.
Denninghoff VC; Kahn AG; Falco J; Curutchet HP; Elsner B
Mol Diagn; 2004; 8(4):253-8. PubMed ID: 15887981
[TBL] [Abstract][Full Text] [Related]
9. Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.
Rutkowski P; Nowecki ZI; van Akkooi AC; Kulik J; Wanda M; Siedlecki JA; Eggermont AM; Ruka W
Ann Surg Oncol; 2010 Dec; 17(12):3314-23. PubMed ID: 20607422
[TBL] [Abstract][Full Text] [Related]
10. Quantification of melanoma micrometastases in sentinel lymph nodes using real-time RT-PCR.
Giese T; Engstner M; Mansmann U; Hartschuh W; Arden B
J Invest Dermatol; 2005 Mar; 124(3):633-7. PubMed ID: 15737205
[TBL] [Abstract][Full Text] [Related]
11. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction.
Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E
J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS
J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.
Mangas C; Hilari JM; Paradelo C; Rex J; Fernández-Figueras MT; Fraile M; Alastrue A; Ferrándiz C
Ann Surg Oncol; 2006 Jul; 13(7):910-8. PubMed ID: 16788751
[TBL] [Abstract][Full Text] [Related]
14. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction.
Lukowsky A; Bellmann B; Ringk A; Winter H; Audring H; Fenske S; Sterry W
J Invest Dermatol; 1999 Oct; 113(4):554-9. PubMed ID: 10504440
[TBL] [Abstract][Full Text] [Related]
15. Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies.
Gutzmer R; Kaspari M; Brodersen JP; Mommert S; Völker B; Kapp A; Werfel T; Kiehl P
Histopathology; 2002 Dec; 41(6):510-8. PubMed ID: 12460203
[TBL] [Abstract][Full Text] [Related]
16. Sentinel node in melanoma patients: triple negativity with routine techniques and PCR as positive prognostic factor for survival.
Denninghoff VC; Falco J; Kahn AG; Trouchot V; Curutchet HP; Elsner B
Mod Pathol; 2008 Apr; 21(4):438-44. PubMed ID: 18223554
[TBL] [Abstract][Full Text] [Related]
17. Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods.
Rimoldi D; Lemoine R; Kurt AM; Salvi S; Berset M; Matter M; Roche B; Cerottini JP; Guggisberg D; Krischer J; Braun R; Willi JP; Antonescu C; Slosman D; Lejeune FJ; Liénard D;
Melanoma Res; 2003 Oct; 13(5):511-20. PubMed ID: 14512793
[TBL] [Abstract][Full Text] [Related]
18. Detection of tyrosinase mRNA in the sentinel lymph nodes of melanoma patients is not a predictor of short-term disease recurrence.
Tatlidil C; Parkhill WS; Giacomantonio CA; Greer WL; Morris SF; Walsh NM
Mod Pathol; 2007 Apr; 20(4):427-34. PubMed ID: 17334354
[TBL] [Abstract][Full Text] [Related]
19. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
20. Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'--a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase.
Shidham VB; Qi D; Rao RN; Acker SM; Chang CC; Kampalath B; Dawson G; Machhi JK; Komorowski RA
BMC Cancer; 2003 May; 3():15. PubMed ID: 12735792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
